Pluraflavins, Potent Antitumor Antibiotics from Saccharothrix sp. DSM 12931

The new pluramycin-type antibiotics pluraflavin A, C43H54N2O14, pluraflavin B, C43H56N2O15, and pluraflavin E, C36H41NO14 were isolated from cultures of the Saccharothrix species DSM 12931. The structures of the novel compounds were elucidated with the aid of 2D NMR and mass spectrometric investigat...

Full description

Saved in:
Bibliographic Details
Published inJournal of antibiotics Vol. 54; no. 9; pp. 718 - 729
Main Authors VÉRTESY, LÁSZLÓ, BARBONE, FRANCIS P., CASHMEN, ELIZABETH, DECKER, HEINRICH, EHRLICH, KLAUS, JORDAN, BIRGIT, KNAUF, MARTIN, SCHUMMER, DIETMAR, SEGETH, MARIAN P., WINK, JOACHIM, SEIBERT, GERHARD
Format Journal Article
LanguageEnglish
Published TOKYO JAPAN ANTIBIOTICS RESEARCH ASSOCIATION 2001
JAPAN ANTIBIOT RES ASSN
Japan Antibiotics Research Association
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The new pluramycin-type antibiotics pluraflavin A, C43H54N2O14, pluraflavin B, C43H56N2O15, and pluraflavin E, C36H41NO14 were isolated from cultures of the Saccharothrix species DSM 12931. The structures of the novel compounds were elucidated with the aid of 2D NMR and mass spectrometric investigations. The characteristic structural element of pluraflavins A and B is an additional 4-epi-vancosamine unit at position 13 of the anthraquinone-γ-pyrone ring system. Pluraflavin E has a carboxyl group in this position. Pluraflavin A has a reactive dimethyl epoxide side chain at position 2 of the anthraquinone-γ-pyrone aglycon, which may explain the high activity of the antibiotic. The outstanding biological characteristic of pluraflavin A is its powerful, organ-dependent cytostatic action: the IC50 in the colon carcinoma proliferation assay is in the subnanomolar range.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-8820
1881-1469
DOI:10.7164/antibiotics.54.718